Efficient delivery of Temozolomide using ultrasmall large-pore silica nanoparticles for glioblastoma
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficient delivery of Temozolomide using ultrasmall large-pore silica nanoparticles for glioblastoma
Authors
Keywords
-
Journal
JOURNAL OF CONTROLLED RELEASE
Volume 357, Issue -, Pages 161-174
Publisher
Elsevier BV
Online
2023-03-31
DOI
10.1016/j.jconrel.2023.03.040
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Understanding nanomedicine treatment in an aggressive spontaneous brain cancer model at the stage of early blood brain barrier disruption
- (2022) Phillip W. Janowicz et al. BIOMATERIALS
- Antibody-Based Formats to Target Glioblastoma: Overcoming Barriers to Protein Drug Delivery
- (2022) Saikat Ghosh et al. MOLECULAR PHARMACEUTICS
- Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges
- (2022) Francisco Rodríguez et al. Biomolecules
- Frontiers in the treatment of glioblastoma: Past, present and emerging
- (2021) Taskeen Iqbal Janjua et al. ADVANCED DRUG DELIVERY REVIEWS
- Liquid CO2 Formulated Mesoporous Silica Nanoparticles for pH-Responsive Oral Delivery of Meropenem
- (2021) Aun Raza et al. ACS Biomaterials-Science & Engineering
- Microfluidic assembly of pomegranate-like hierarchical microspheres for efflux regulation in oral drug delivery
- (2021) Aun Raza et al. Acta Biomaterialia
- In vitro model for predicting the access and distribution of drugs in the brain using hCMEC/D3 cells
- (2021) Bárbara Sánchez-Dengra et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Clofazimine functionalized polymeric nanoparticles for brain delivery in the tuberculosis treatment
- (2021) Renata Ribeiro de Castro et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy
- (2021) P. Soma Yasaswi et al. JOURNAL OF CONTROLLED RELEASE
- Spatio-temporal analysis of nanoparticles in live tumor spheroids impacted by cell origin and density
- (2021) Aria Ahmed-Cox et al. JOURNAL OF CONTROLLED RELEASE
- Clinical translation of silica nanoparticles
- (2021) Taskeen Iqbal Janjua et al. Nature Reviews Materials
- Milk protein-shelled gold nanoparticles with gastrointestinally active absorption for aurotherapy to brain tumor
- (2021) Hyung Shik Kim et al. Bioactive Materials
- Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis
- (2020) Lina Marenco-Hillembrand et al. JOURNAL OF NEURO-ONCOLOGY
- Understanding the Uptake of Nanomedicines at Different Stages of Brain Cancer Using a Modular Nanocarrier Platform and Precision Bispecific Antibodies
- (2020) Zachary H. Houston et al. ACS Central Science
- Comment in Response to “Temozolomide in Glioblastoma Therapy: Role of Apoptosis, Senescence and Autophagy etc. by B. Kaina”
- (2020) Mike-Andrew Westhoff et al. Biomedicines
- Effect of Nanoparticle Composition, Size, Shape, and Stiffness on Penetration Across the Blood–Brain Barrier
- (2020) Tyler D. Brown et al. ACS Biomaterials-Science & Engineering
- ApoE-Targeting Increases the Transfer of Solid Lipid Nanoparticles with Donepezil Cargo across a Culture Model of the Blood–Brain Barrier
- (2020) Gizem Rüya Topal et al. Pharmaceutics
- PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution
- (2019) Zahid Hussain et al. Drug Delivery and Translational Research
- Blood-brain barrier receptors and transporters: an insight on their function and how to exploit them through nanotechnology
- (2019) Rui Pedro Moura et al. Expert Opinion on Drug Delivery
- Rationally Designed Dendritic Silica Nanoparticles for Oral Delivery of Exenatide
- (2019) Muhammad Mustafa Abeer et al. Pharmaceutics
- Encapsulation and Controlled Release of Resveratrol Within Functionalized Mesoporous Silica Nanoparticles for Prostate Cancer Therapy
- (2019) Zanib Chaudhary et al. Frontiers in Bioengineering and Biotechnology
- Anionic nanoparticles enable the oral delivery of proteins by enhancing intestinal permeability
- (2019) Nicholas G. Lamson et al. Nature Biomedical Engineering
- Improved Brain Penetration and Antitumor Efficacy of Temozolomide by Inhibition of ABCB1 and ABCG2
- (2018) Mark C. de Gooijer et al. NEOPLASIA
- Dual functionalized liposome-mediated gene delivery across triple co-culture blood brain barrier model and specific in vivo neuronal transfection
- (2018) Bruna dos Santos Rodrigues et al. JOURNAL OF CONTROLLED RELEASE
- Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma
- (2018) Shabierjiang JIAPAER et al. NEUROLOGIA MEDICO-CHIRURGICA
- Polyethylene glycol-decorated doxorubicin/carboxymethyl chitosan/gold nanocomplex for reducing drug efflux in cancer cells and extending circulation in blood stream
- (2018) Jin-Wook Kang et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Combination of 3-methyladenine therapy and Asn-Gly-Arg (NGR)-modified mesoporous silica nanoparticles loaded with temozolomide for glioma therapy in vitro
- (2018) Peng Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433)
- (2017) Sonali Kumari et al. Scientific Reports
- PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
- (2016) Jung Soo Suk et al. ADVANCED DRUG DELIVERY REVIEWS
- Temozolomide analogs with improved brain/plasma ratios – Exploring the possibility of enhancing the therapeutic index of temozolomide
- (2016) Roopa Rai et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Survival in glioblastoma: a review on the impact of treatment modalities
- (2016) P. D. Delgado-López et al. Clinical & Translational Oncology
- In vitro models of the blood–brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use
- (2016) Hans C Helms et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Feasibility Study of the Permeability and Uptake of Mesoporous Silica Nanoparticles across the Blood-Brain Barrier
- (2016) Habib Baghirov et al. PLoS One
- Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells
- (2015) Jessian L. Munoz et al. CANCER LETTERS
- Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma
- (2015) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Airyscan detector from ZEISS: confocal imaging with improved signal-to-noise ratio and super-resolution
- (2015) Joseph Huff NATURE METHODS
- CNS Anticancer Drug Discovery and Development Conference White Paper
- (2015) Victor A. Levin et al. NEURO-ONCOLOGY
- Combined Delivery of Temozolomide and Anti-miR221 PNA Using Mesoporous Silica Nanoparticles Induces Apoptosis in Resistant Glioma Cells
- (2015) Alessandro Bertucci et al. Small
- Temozolomide and Radiotherapy versus Radiotherapy Alone in High Grade Gliomas: A Very Long Term Comparative Study and Literature Review
- (2015) Salvatore Parisi et al. Biomed Research International
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- pH-Responsive Nutraceutical-Mesoporous Silica Nanoconjugates with Enhanced Colloidal Stability
- (2013) Rémy Guillet-Nicolas et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Glioblastoma survival in the United States before and during the temozolomide era
- (2011) Derek R. Johnson et al. JOURNAL OF NEURO-ONCOLOGY
- Temozolomide: Mechanisms of Action, Repair and Resistance
- (2011) Jihong Zhang et al. Current Molecular Pharmacology
- Native albumin for targeted drug delivery
- (2010) Elena Neumann et al. Expert Opinion on Drug Delivery
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search